<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04277572</url>
  </required_header>
  <id_info>
    <org_study_id>17200395</org_study_id>
    <nct_id>NCT04277572</nct_id>
  </id_info>
  <brief_title>Outcomes of Surgery of Aortic Valve</brief_title>
  <acronym>Aortic Surgery</acronym>
  <official_title>Outcomes of Different Modalities for Surgery of Aortic Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overall Goal: To study the outcomes of patients undergoing aortic valve surgeries, different
      approaches such as standard aortic valve replacement, aortic valve repair, novel techniques
      as Ozaki's procedure and their subsequent results and complications.

        -  Objective 1: Identify predictors of complications following different types of aortic
           valve surgery accordingly.

        -  Objective 2: Determine the value of each type in terms of advantages and disadvantages.

        -  Objective3: Assess outcomes such as postoperative life expectancy, hospital stay,
           prognosis and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcomes of different techniques of aortic valve surgery in the indicated patients for each type of surgery such as :</measure>
    <time_frame>Up to one week</time_frame>
    <description>Number of days of postoperative hospital stay.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>Aortic valve replacement</arm_group_label>
    <description>using different ways of aortic valve replacement either by prosthetic valves or by ozaki technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aortic valve replacement</intervention_name>
    <description>Aortic valve surgery</description>
    <arm_group_label>Aortic valve replacement</arm_group_label>
    <other_name>Ozaki procedure</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients registered in cardiac surgery department database, and who meet the listed
        inclusion and exclusion criteria will be eligible for the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with severe symptomatic aortic valve lesion.

          2. Asymptomatic aortic insufficiency patients with left ventricular dysfunction or
             significant left ventricular dilatation (LV end diastolic diameter&gt;70 mm or LV end
             systolic diameter&gt;50 mm.

          3. Patients with aortic regurgitation caused by:

               -  a dilated aortic annulus

               -  conjoined cusp prolapse in bicuspid aortic valves (BAV)

               -  single cusp prolapse in tricuspid aortic valves

               -  aortic valve cusp perforation from endocarditis

        Exclusion Criteria:

          -  Patients with previous aortic root or valve surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Gamal Thabet Ahmed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

